NCCN Tumor Boards: Management of Early-Stage, Invasive, Non-Metastatic Breast Cancer

Target Audience
This educational program is designed to meet the educational needs of physicians/oncologists, nurse practitioners, nurses, physician assistants/associates, pharmacists, and other health care professionals who manage patients with cancer.
Learning Objectives
Following this activity, participants should be able to:
- Review new and emerging data in the locoregional management of invasive non-metastatic breast cancer and integrate key findings into clinical practice.
- Recognize key factors that influence selection of systemic neoadjuvant/adjuvant therapy for patients with non-metastatic breast cancer.
- Describe how interdisciplinary collaboration among surgeons, radiation oncologists, medical oncologists, and shared-decision with the patient is essential for individualized treatment to optimize outcomes and minimize morbidity.
Course summary
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation



UCLA Jonsson Comprehensive Cancer Center
It is the policy of NCCN that all planners, faculty, moderators, authors, reviewers and anyone involved in the planning and delivery of NCCN continuing education activities are expected to disclose ALL financial relationships they have had in the past 24 months with ineligible companies. The ACCME Standards for Integrity and Independence require that individuals who refuse to provide this information will be disqualified from involvement in the planning and implementation of accredited continuing education presented by NCCN. NCCN identifies, mitigates and discloses to learners all relevant financial relationships.
AstraZeneca Pharmaceuticals LP: Consulting Fee; Grant/Research Support
Bristol Myers Squibb Consulting Fee
Daiichi- Sankyo Co.: Consulting Fee; Grant/Research Support
Eli Lilly and Company: Consulting Fee; Grant/Research Support
Genentech, Inc.: Consulting Fee; Grant/Research Support
Gilead Sciences, Inc.: Consulting Fee; Grant/Research Support
Menarini Group, Alyssum Therapeutics, Vyome Therapeutics: Consulting Fee; Grant/Research Support
Merck & Co., Inc.: Consulting Fee; Grant/Research Support
Novartis Pharmaceuticals Corporation: Consulting Fee; Grant/Research Support
Pfizer Inc.: Consulting Fee; Grant/Research Support
AstraZeneca Pharmaceuticals LP: Honoraria
![]() | In support of improving patient care, National Comprehensive Cancer Network (NCCN) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team. |
Physicians
NCCN designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
NCCN designates this educational activity for a maximum of 1.0 contact hour.
NCCN designates this knowledge-based continuing education activity for 1.0 contact hour (0.10 CEUs) of continuing education credit.
NCCN has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 1.0 AAPA Category 1 CME credit. PAs should only claim credit commensurate with the extent of their participation.
This program has been pre-approved by The Commission to provide continuing education credit to CCM® Board-Certified Case Managers. The course is approved for 1.0 CE contact hour.
Available Credit
- 1.00 AAPA Category 1 CME credit
- 1.00 ACPE contact hours
- 1.00 AMA PRA Category 1 Credit™
- 1.00 ANCC contact hours
- 1.00 CCM clock hours
- 1.00 Participation
Click the Take Course button to claim credit for the live webinar.
- The webinar was presented live one time only on Friday, October 30, 2026.
- Missed the live webinar? The recorded activity is available here.
NCCN Non-Discrimination/Harassment Policy – Affiliated Persons and Volunteers
NCCN is committed to providing workplaces and events that are free from discrimination or harassment of any kind for all participants, and has a zero-tolerance policy for any such conduct. NCCN requires individuals participating on NCCN Guidelines Panels, standing and ad hoc committees, meetings and seminars, or other NCCN-affiliated activities and events to adhere to this policy.
To access this policy including reporting procedures, please visit NCCN.org/non-discrimination.
Required Hardware/software
To complete this activity, you will need:
- A device with an Internet connection and sound playback capability (speakers or a headset)
- Adobe Reader or other PDF reader software for certificate viewing/printing

Facebook
X
LinkedIn
Forward